首页> 美国卫生研究院文献>Matrix Biology Plus >A proteome comparison between human fetal and mature renal extracellular matrix identifies EMILIN1 as a regulator of renal epithelial cell adhesion
【2h】

A proteome comparison between human fetal and mature renal extracellular matrix identifies EMILIN1 as a regulator of renal epithelial cell adhesion

机译:人胎儿和成熟肾细胞外基质之间的蛋白质组比较鉴定Emilin1作为肾上皮细胞粘附的调节剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cell-based approaches using tissue engineering and regenerative medicine to replace damaged renal tissue with 3D constructs is a promising emerging therapy for kidney disease. Besides living cells, a template provided by a scaffold based on biomaterials and bioactive factors is needed for successful kidney engineering. Nature's own template for a scaffolding system is the extracellular matrix (ECM). Research has focused on mapping the mature renal ECM; however, the developing fetal ECM matches more the active environment required in 3D renal constructs. Here, we characterized the differences between the human fetal and mature renal ECM using spectrometry-based proteomics of decellularized tissue. We identified 99 different renal ECM proteins of which the majority forms an overlapping core, but also includes proteins enriched in either the fetal or mature ECM. Relative protein quantification showed a significant dominance of EMILIN1 in the fetal ECM. We functionally tested the role of EMILIN1 in the ECM using a novel methodology that permits the reliable anchorage of native cell-secreted ECM to glass coverslips. Depletion of EMILIN1 from the ECM layer using siRNA mediated knock-down technologies does not affect renal epithelial cell growth, but does promote migration. Lack of EMILIN1 in the ECM layer reduces the adhesion strength of renal epithelial cells, shown by a decrease in focal adhesion points and associated stress fibers. We showed in this study the importance of a human renal fetal and mature ECM catalogue for identifying promising ECM components that have high implementation potential in scaffolds for 3D renal constructs.
机译:使用组织工程和再生药物用3D构建体取代受损肾组织的细胞的方法是肾病的有望的新出现治疗。除了活细胞,还需要基于生物材料和生物活性因子提供的支架提供的模板,以获得成功的肾工程。对脚手架系统的自然自己的模板是细胞外基质(ECM)。研究专注于映射成熟的肾ECM;然而,显影胎儿ECM与3D肾脏结构所需的活动环境更多地匹配。这里,我们用脱细胞化组织的光谱蛋白质组学表征人胎儿和成熟肾ECM之间的差异。我们确定了99种不同的肾ECM蛋白,其中大多数形成重叠的核心,还包括富含胎儿或成熟ECM的蛋白质。相对蛋白质量化显示胎儿ECM中的埃米林1的显着优势。我们在功能上使用一种新的方法测试Emilin1在ECM中的作用,这些方法允许天然细胞分泌的ECM的可靠锚固到玻璃盖玻片。使用siRNA介导的淘汰技术从ECM层耗尽Emilin1不会影响肾上皮细胞生长,但促进迁移。 ECM层中缺乏Emilin1降低了肾上皮细胞的粘附强度,通过局灶性粘附点和相关应力纤维的降低显示。我们在这研究中表明,人类肾胎儿和成熟ECM目录的重要性,用于识别具有高于3D肾构建结构的支架中具有高实施潜力的有前途的ECM组件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号